Over 537 million diabetic people suffer daily from managing the disease, which may require multiple insulin injections/doses every day.
Betalin is developing a micro-pancreas to liberate diabetic patients from their daily insulin dependency. It responds to the patient’s blood glucose levels by releasing controlled therapeutic levels of insulin for at least 12 months.
Company Details
- Employees
- 10
- Founded
- -
- Address
- Jerusalem , Hadassah Ein Karem Campus, Il
- Phone
- 972779400370
- in****@****ics.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- betalintherapeutics.com
- HQ
- Jerusalem
Betalin Therapeutics Ltd. Questions
Betalin Therapeutics Ltd.'s helpline number is 972779400370
Betalin Therapeutics Ltd.'s website is betalintherapeutics.com
Betalin Therapeutics Ltd.'s LinkedIn profile is https://il.linkedin.com/company/betalin-therapeutics
Betalin Therapeutics Ltd. has
10 employees.
View email and phone details for 10
employees at Betalin Therapeutics Ltd..
Betalin Therapeutics Ltd.'s industry is
Biotechnology Research
Betalin Therapeutics Ltd.'s top competitors are
Pharmacyte Biotech,
Cytoreason,
Orgenesis Inc.,
Unicyte Ag,
Sonovia Ltd,
Nextcell Pharma Ab,
Viacyte,
Seraxis,
Altucell,
Osiris Therapeutics.
Betalin Therapeutics Ltd.'s support email address is info@betalintherapeutics.com
Betalin Therapeutics Ltd.'s categories are Biotechnology Research
Betalin Therapeutics Ltd.'s founding year is 2016
